Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Central Securities Corp. is a publicly owned investment manager. The firm invests in the public equity markets of the United States. It also invests on bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations. Central Securities Corp. was founded on October 1, 1929 and is based in New York, New York.

Central Securities Corp.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

PRESS RELEASE  NO. 11 / 2025 ZEALAND PHARMA CONFERENCE CALL ON AUGUST 14 AT 2PM CET (8AM ET) TO PRESENT SECOND QUARTER 2025 FINANCIAL RESULTS COPENHAGEN, DENMARK,AUGUST 7, 2025ZEALAND PHARMA A/S (NASDAQ COPENHAGEN: ZEAL) (CVR-NO.

ZEALAND PHARMA CONFERENCE CALL ON AUGUST 14 AT 2PM CET (8AM ET) TO PRESENT SECOND QUARTER 2025 FINANCIAL RESULTS

AUGUST 1, 2025  6.00 PM CET REGULATED INFORMATION - CONTAINS INSIDE INFORMATION AGFA-GEVAERT NV SIGNS NEW REVOLVING CREDIT FACILITY MORTSEL, BELGIUM  AUGUST 1, 2025  6.00 P.M. CET AGFA-GEVAERT NV HAS SIGNED A NEW 3 YEAR REVOLVING CREDIT FACILITY OF 180 MILLION EURO.

AGFA-GEVAERT NV SIGNS NEW REVOLVING CREDIT FACILITY - REGULATED INFORMATION - CONTAINS INSIDE INFORMATION

NEW YORK--(BUSINESS WIRE)--CENTRAL SECURITIES CORPORATION (NYSE AMERICAN: CET), A CLOSED-END INVESTMENT COMPANY, TODAY RELEASED ITS REPORT TO STOCKHOLDERS FOR THE SIX MONTHS ENDED JUNE 30, 2025. FIGURES AS OF JUNE 30, 2025 COMPARED WITH THOSE OF ONE YEAR AGO, ARE AS FOLLOWS:  JUNE 30, 2025 JUNE 30, 2024 NET ASSETS PER COMMON SHARE $57.63 $52.58 NET ASSETS $1,666,259,626 $1,492,593,177 SHARES OUTSTANDING 28,913,659 28,387,828 ADDITIONAL DETAILS ARE AVAILABLE AT WWW.CENTRALSECURITIES.COM.

CENTRAL SECURITIES CORPORATION RELEASES REPORT TO STOCKHOLDERS

$949 MILLION IN SECOND QUARTER GLOBAL PRODUCT NET SALES VYVGART SC LAUNCH IN CIDP PROGRESSES WITH MORE THAN 2,500 PATIENTS ON TREATMENT GLOBALLY ARGX-119 TO ADVANCE TO REGISTRATIONAL STUDY IN CMS FOLLOWING POSITIVE PROOF OF CONCEPT DATA; THREE ADDITIONAL TOPLINE DATA READOUTS ACROSS PIPELINE REMAIN ON TRACK FOR SECOND HALF OF 2025 MANAGEMENT TO HOST CONFERENCE CALL TODAY AT 2:30 PM CET (8:30 AM ET) JULY 31, 2025 7:00 AM CET AMSTERDAM, THE NETHERLANDS  ARGENX SE (EURONEXT & NASDAQ: ARGX), A GLOBAL IMMUNOLOGY COMPANY COMMITTED TO IMPROVING THE LIVES OF PEOPLE SUFFERING FROM SEVERE AUTOIMMUNE DISEASES, TODAY ANNOUNCED ITS HALF YEAR 2025 RESULTS AND PROVIDED A SECOND QUARTER BUSINESS UPDATE. WE CONTINUE TO MAKE MEANINGFUL PROGRESS TOWARDS OUR VISION 2030, ADVANCING BOLD INNOVATION THAT HAS ALREADY REACHED MORE THAN 15,000 PATIENTS GLOBALLY SAID TIM VAN HAUWERMEIREN, CHIEF EXECUTIVE OFFICER OF ARGENX.

ARGENX REPORTS HALF YEAR 2025 FINANCIAL RESULTS AND PROVIDES SECOND QUARTER BUSINESS UPDATE

PARIS, FRANCE  JULY 17, 2025 Q2 2025 FINANCIAL RESULTS AND CONFERENCE CALL VIRIDIEN WILL ANNOUNCE ITS SECOND QUARTER 2025 RESULTS ON THURSDAY, JULY 31, AFTER MARKET CLOSE. THE PRESS RELEASE AND PRESENTATION WILL BE MADE AVAILABLE ON WWW.VIRIDIENGROUP.COM AT 5.45 PM (CET) AN ENGLISH-LANGUAGE CONFERENCE CALL IS SCHEDULED AT 6.00 PM (CET) ON THE SAME DAY PARTICIPANTS MUST REGISTER FOR THE CONFERENCE CALL BY CLICKING HERE TO RECEIVE A DIAL-IN NUMBER AND PIN CODE.

ANNOUNCEMENT OF Q2 2025 FINANCIAL RESULTS ON THURSDAY, JULY 31, AFTER MARKET CLOSE

BOSTON--(BUSINESS WIRE)--THE BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM (THE FEDERAL RESERVE) INFORMED SANTANDER HOLDINGS USA, INC. (SHUSA) ON JUNE 27, 2025, OF SHUSA'S UPDATED STRESS CAPITAL BUFFER (SCB) REQUIREMENT, WHICH BECOMES EFFECTIVE ON OCTOBER 1, 2025. SHUSA'S UPDATED SCB WILL BE 3.4% OF ITS COMMON EQUITY TIER 1 CAPITAL (CET1), RESULTING IN AN OVERALL CET1 CAPITAL REQUIREMENT OF 7.9%. SHUSA'S STRONG CAPITALIZATION SUPPORTS OUR PLANNED CAPITAL ACTIONS, AND THE UPDATED SCB.

SANTANDER HOLDINGS USA, INC. ANNOUNCES 2025 STRESS CAPITAL BUFFER

REGULATED INFORMATION JUNE 13, 2025, 7:00AM CET / 1:00AM ET NYXOAH SA (EURONEXT BRUSSELS/NASDAQ: NYXH) RUE EDOUARD BELIN 12, 1435 MONT-SAINT-GUIBERT, BELGIUM(HEREINAFTER THE COMPANY) INVITATION TO ATTEND THE EXTRAORDINARY SHAREHOLDERS' MEETING OF THE COMPANY TO BE HELD ON JULY 2, 2025 THE BOARD OF DIRECTORS OF THE COMPANY IS PLEASED TO INVITE ITS SECURITIES HOLDERS TO ATTEND THE EXTRAORDINARY SHAREHOLDERS' MEETING OF THE COMPANY, TO BE HELD ON WEDNESDAY, JULY 2, 2025 AT 2:00P.M. CET AT THE COMPANY'S SEAT, OR AT SUCH OTHER PLACE AS WILL BE INDICATED PRIOR TO SUCH TIME.

INVITATION TO ATTEND THE EXTRAORDINARY SHAREHOLDERS' MEETING OF THE COMPANY TO BE HELD ON JULY 2, 2025

NEW YORK--(BUSINESS WIRE)--THE BOARD OF DIRECTORS OF CENTRAL SECURITIES CORPORATION (NYSE AMERICAN: CET), A CLOSED-END INVESTMENT COMPANY, TODAY DECLARED THE FOLLOWING DIVIDEND:    EX- AND RECORD  PAYMENT CLASS OF STOCK RATE  DATE  DATE COMMON STOCK $0.25  6/17/25  6/27/25 OF THE $0.25 PER SHARE TO BE PAID ON JUNE 27, 2025, $0.04 IS EXPECTED TO BE TAXABLE AS ORDINARY INCOME AND $0.21 IS EXPECTED TO BE TAXABLE AS LONG-TERM CAPITAL GAIN. THE FINAL TAX BREAKDOWN OF ALL AMOUNTS PAID DURING.

CENTRAL SECURITIES CORPORATION DECLARES DIVIDEND

REGULATED INFORMATION MAY 9, 2025, 7:00AM CET / 1:00AM ET NYXOAH SA (EURONEXT BRUSSELS: NYXH) RUE EDOUARD BELIN 12, 1435 MONT-SAINT-GUIBERT, BELGIUM(HEREINAFTER THE COMPANY) INVITATION TO ATTEND THE ANNUAL AND THE EXTRAORDINARY SHAREHOLDERS' MEETINGS OF THE COMPANY TO BE HELD ON JUNE 11, 2025 THE BOARD OF DIRECTORS OF THE COMPANY IS PLEASED TO INVITE ITS SECURITIES HOLDERS TO ATTEND THE ANNUAL SHAREHOLDERS' MEETING OF THE COMPANY, TO BE HELD ON WEDNESDAY, JUNE 11, 2025 AT 2:00 P.M. CET AT THE COMPANY'S SEAT, OR AT SUCH OTHER PLACE AS WILL BE INDICATED PRIOR TO SUCH TIME.

INVITATION TO ATTEND THE ANNUAL AND THE EXTRAORDINARY SHAREHOLDERS' MEETINGS OF THE COMPANY TO BE HELD ON JUNE 11, 2025

$790 MILLION IN FIRST QUARTER GLOBAL PRODUCT NET SALES FIRST PATIENTS TREATED WITH VYVGART HYTRULO PRE-FILLED SYRINGE FOR SELF-INJECTION IN US AND GERMANY CIDP GLOBAL EXPANSION WITH POSITIVE CHMP OPINION FOR VYVGART-SC (VIAL AND PRE-FILLED SYRINGE) IN EU MANAGEMENT TO HOST CONFERENCE CALL TODAY AT 2:30 PM CET (8:30 AM ET) MAY 8, 2025, 7:00 AM CET AMSTERDAM, THE NETHERLANDS  ARGENX SE (EURONEXT & NASDAQ: ARGX), A GLOBAL IMMUNOLOGY COMPANY COMMITTED TO IMPROVING THE LIVES OF PEOPLE SUFFERING FROM SEVERE AUTOIMMUNE DISEASES, TODAY ANNOUNCED ITS FIRST QUARTER 2025 FINANCIAL RESULTS AND PROVIDED A BUSINESS UPDATE. WE CONTINUE TO EXECUTE ON OUR BOLD INNOVATION AGENDA, GUIDED BY OUR VISION 2030' TO REACH 50,000 PATIENTS ACROSS 10 LABELED INDICATIONS, SAID TIM VAN HAUWERMEIREN, CHIEF EXECUTIVE OFFICER OF ARGENX.

Central Securities Corp.

CET

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Central Securities Corp.

CET.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CET